Understanding of diabetes prevention studies: questionnaire survey of professionals in diabetes care
- 23 May 2006
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 49 (8) , 1742-1746
- https://doi.org/10.1007/s00125-006-0290-8
Abstract
Diabetes prevention studies have reported reductions of diabetes risk by up to 60%. Since the underlying metabolic changes are small, the clinical significance of this effect may be overestimated. The present survey explores the extent to which different formats of presenting study results may influence diabetes healthcare professionals' perceptions of the importance of intervention effects on diabetes risk. Participants of three European diabetes conferences (160 nurse educators, 112 physicians, 27 other professionals) were presented with a questionnaire that included nine items, in which results from three diabetes prevention studies were presented in different ways. Participation rate was 96%. Effects were interpreted as important or very important by 92% (255/276) when results were presented as proportions of subjects with diabetes (14% intervention group, 29% control group), by 87% (248/285) when results were communicated as a risk reduction of 57%, by 39% (110/284) when the corresponding fasting plasma glucose values were presented (mean difference 0.3 mmol/l), and by 18% (52/283) when glycosylated haemoglobin values were used (6.0 vs 6.1%). Corresponding results of the three diabetes prevention studies were rated as being of identical importance by only 23, 13 and 16% of participants, respectively. Healthcare professionals rate the benefit of preventive interventions substantially higher when changes in diabetes risk are communicated rather than related glycaemic parameters. Transformation of continuous metabolic data into diagnostic categories may impair understanding of study effects.Keywords
This publication has 23 references indexed in Scilit:
- Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authorsBMJ, 2005
- Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone TrialDiabetologia, 2004
- Acarbose for type 2 diabetes preventionThe Lancet, 2002
- Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trialThe Lancet, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Presenting Risk Information A Review of the Effects of Framing and other Manipulations on Patient OutcomesJournal of Health Communication, 2001
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Evidence based purchasing: understanding results of clinical trials and systematic reviewsBMJ, 1995
- Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentrationBMJ, 1994
- Absolutely relative: How research results are summarized can affect treatment decisionsThe American Journal of Medicine, 1992